Implementation of circulating cell-free DNA screening for fetal aneuploidies
Circulating cell-free DNA (cfDNA) consists of extracellular DNA fragments that circulate in the bloodstream and derived from apoptotic cells such as hematopoietic cells or placental trophoblast cells during pregnancy.
Saved in:
| Main Authors: | Madrigal Bajo Irene, Jodar Bifet Meritxell, Badenas Orquin Celia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2025-03-01
|
| Series: | Advances in Laboratory Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/almed-2025-0055 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NIPT of Maternal Plasma-Originated cfDNA: Applications and Guide for the Implementation
by: Fernández Martínez FJ, et al.
Published: (2025-04-01) -
The Phenomenon of Prenatal Childhood (Methodology for Building a Program of Medical, Psychological and Pedagogical Support for Child Development in the Dyad “Mother – Prenatal Child”)
by: Mikhail L. Lazarev, et al.
Published: (2025-07-01) -
The relationship between clinical-anamnestic data and cell-free fetal DNA level assessed by semiconductor sequencing within non-invasive prenatal testing
by: E. S. Vashukova, et al.
Published: (2025-01-01) -
Aneuploidy screening in women of advanced age in the public healthcare setting of a low- to middle- income country – an observational cohort study
by: L Geerts, et al.
Published: (2025-08-01) -
A retrospective analysis of 6942 amniocentesis cases
by: Qingsha An, et al.
Published: (2025-08-01)